Elevated globotriaosylsphingosine is a hallmark of Fabry diseaseJohannes M. F. G. Aerts, Ben J. H. M. Poorthuis, Anneke Strijland et al.|Proceedings of the National Academy of Sciences|2008Cited by 725
Characterization of Classical and Nonclassical Fabry Disease: A Multicenter StudyMaarten Arends, Carla E. M. Hollak, Christoph Wanner et al.|Journal of the American Society of Nephrology|2016Cited by 421
Recommendations for initiation and cessation of enzyme replacement therapy in patients with Fabry disease: the European Fabry Working Group consensus documentMarieke Biegstraaten, Carla E. M. Hollak, Reynir Arngrı́msson et al.|Orphanet Journal of Rare Diseases|2015Cited by 345
Elevated plasma glucosylsphingosine in Gaucher disease: relation to phenotype, storage cell markers, and therapeutic responseNick Dekker, Johannes M. F. G. Aerts, Laura van Dussen et al.|Blood|2011Cited by 288
Plasma globotriaosylsphingosine: Diagnostic value and relation to clinical manifestations of Fabry diseaseSaskia M. Rombach, Johannes M. F. G. Aerts, Natashe Lemos Dekker et al.|Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease|2010Cited by 229